NCT06550895
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06550895
Title A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma (MonumenTAL-8)
Acronym MonumenTAL-8
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Royal Prince Alfred Hospital Camperdown 2050 Australia Details
Austin Hospital Heidelberg 3084 Australia Details
Peter MacCallum Cancer Centre Melbourne 3000 Australia Details
The Alfred Hospital Melbourne 3004 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field